Search Results 7251-7260 of 34329 for oral

1. Tongue cancer - Doctors and departments - Mayo Clinic

   Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...

2. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Patients who received oral bisphosphonate within ≤ 12 weeks, IV zoledronic acid (Reclast) ≤ 52 weeks, or denosumab ≤ 24 weeks will also be excluded.

3. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

   Patients with mild claustrophobia are eligible and have the option to take 1mg oral Lorazepam prior to the MRI, if needed;; Allergy to gadolinium-containing ...

4. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

   The purpose of this research study is to see if oral everolimus is a tolerable and effective treatment for sporadic angiomyolipomas tumors of the kidney.

5. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   Must be able and willing to swallow and retain oral medication. Serum or urine pregnancy test must be negative in premenopausal women within 14 days of ...

6. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   ... oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency ...

7. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   ... oral contraceptives, some intrauterine contraceptive devices, sexual abstinence, or a vasectomized partner, and/or unwilling to refrain from donating eggs ...

8. Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors - Mayo Clinic

   Patients with glucose intolerance or diabetes whose blood glucose levels are consistently well controlled with the use of oral hypoglycemic agents and/or ...

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Salivary gland tumor, Laryngeal cancer ...

10. Benign peripheral nerve tumor - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Melanoma, Tonsil cancer, Skin cancer, Squamous cell ...